These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4843743)

  • 1. A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia.
    Rosenberg RD; Colman RW; Lorand L
    Br J Haematol; 1974 Feb; 26(2):269-84. PubMed ID: 4843743
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).
    Lorand L; Maldonado N; Fradera J; Atencio AC; Robertson B; Urayama T
    Br J Haematol; 1972 Jul; 23(1):17-27. PubMed ID: 5045959
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rational diagnosis in blood coagulation disorders].
    Spannagl M; Schramm W
    Internist (Berl); 1994 Jul; 35(7):646-51. PubMed ID: 7928167
    [No Abstract]   [Full Text] [Related]  

  • 4. An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations.
    Otis PT; Feinstein DI; Rapaport SI; Patch MJ
    Blood; 1974 Dec; 44(6):771-81. PubMed ID: 4214572
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired plasma factor XIII deficiencies.
    Tosetto A; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrin stabilizing factor, factor XIII.
    Duckert F
    Blut; 1973 Mar; 26(3):177-9. PubMed ID: 4571301
    [No Abstract]   [Full Text] [Related]  

  • 7. An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin cross-linking.
    Fear JD; Miloszewski KJ; Losowsky MS
    Acta Haematol; 1984; 71(5):304-9. PubMed ID: 6429995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coagulation physiology research in a new coagulation disorder. Deficiency of a fibrin-stabilizing factor].
    DUCKERT F; JUNG E; SHMERLING DH
    Schweiz Med Wochenschr; 1961 Sep; 91():1139-40. PubMed ID: 13888166
    [No Abstract]   [Full Text] [Related]  

  • 9. A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.
    BAKER SJ; JACOB E
    J Clin Pathol; 1960 May; 13(3):214-9. PubMed ID: 13796035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic disease associated with inhibitors of fibrin cross-linkage.
    Lewis JH
    Ann N Y Acad Sci; 1972 Dec; 202():213-9. PubMed ID: 4508924
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increased thrombin time in a patient with multiple myeloma].
    Bohler A; Redondo M; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEFECTIVE FIBRINASE ACTIVITY IN TWO BROTHERS.
    HAMPTON JW; BIRD RM; HAMMARSTEN DM
    J Lab Clin Med; 1965 Mar; 65():469-74. PubMed ID: 14261328
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryofibrinogenaemia and skin ulcers: treatment with plasmapheresis.
    Copeman PW
    Br J Dermatol; 1979 Jul; 101 Suppl 17():57-8. PubMed ID: 465341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between fibrinogen concentration, fibrin-stabilizing factor activity and fibrinolysis in hemorrhagic disease in children].
    Bebeshko VG; Donskaia SB
    Lab Delo; 1987; (7):520-2. PubMed ID: 2442484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anomaly of polymerization of fibrin in a case of gamma-A myeloma].
    Krick JA; Ménaché D
    Nouv Rev Fr Hematol; 1966; 6(5):744-8. PubMed ID: 4165868
    [No Abstract]   [Full Text] [Related]  

  • 17. A painful bleeding syndrome associated with increased fibrinolytic activity.
    Rowell NR
    Br J Dermatol; 1974 Nov; 91(5):591-6. PubMed ID: 4433477
    [No Abstract]   [Full Text] [Related]  

  • 18. CONGENITAL DEFICIENCY OF FIBRIN-STABILIZING FACTOR. OBSERVATION OF A NEW CASE.
    BARRY A; DELAGE JM
    N Engl J Med; 1965 May; 272():943-7. PubMed ID: 14274451
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
    ALKJAERSIG N; FLETCHER AP; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.